VPIM
STRO icon

Vanguard Personalized Indexing Management’s Sutro Biopharma STRO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,018
Closed -$52.3K – 2065
2025
Q3 		$52.3K Sell
6,018
-44
-0.7% -$374 ﹤0.01% 1897
2025
Q2 		$43.3K Buy
6,062
+3,856
+175% +$31.5K ﹤0.01% 1847
2025
Q1 		$14.3K Buy
2,206
+1,165
+112% +$18.3K ﹤0.01% 1806
2024
Q4 		$19.2K Buy
+1,041
New +$31.8K ﹤0.01% 1771

Other funds holding STRO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Personalized Indexing Management's STRO Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Sutro Biopharma (STRO) in Q4 2025, closing a stake of 6,018 shares — an estimated $52.3K sold.

Vanguard Personalized Indexing Management first reported a position in STRO in Q4 2024 and held it in 4 quarters. The position peaked at $52.3K in Q3 2025. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Sutro Biopharma position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 6,018 Sutro Biopharma shares in Q4 2025, an estimated $52.3K.
  • Vanguard Personalized Indexing Management first reported a position in Sutro Biopharma in Q4 2024 and held it in 4 quarters.
  • Vanguard Personalized Indexing Management's Sutro Biopharma position peaked at $52.3K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.